A practical synthesis of 2-((1H-pyrrolo[2,3-b]pyridine-4-yl)methylamino)-5- fluoronicotinic acid.
Xin Wang, Ben Zhi, Jean Baum, Ying Chen, Richard Crockett, Liang Huang, Shawn Eisenberg, John Ng, Robert Larsen, Mike Martinelli, Paul Reider
Index: J. Org. Chem. 71 , 4021-4023, (2006)
Full Text: HTML
Abstract
A practical synthesis of a key pharmaceutical intermediate, 2-[(1H-pyrrolo[2,3-b]pyridine-4-yl)methylamino]-5-fluoronicotinic acid (1), is described. To introduce the aminomethyl moiety of 2 via a palladium-catalyzed cyanation/reduction sequence, a regioselective chlorination of 7-azaindole via the N-oxide was developed. A highly selective monodechlorination of 2,6-dichloro-5-fluoronicotinic acid was discovered to afford the nicotinic acid 3. The two building blocks 2 and 3 were then coupled to complete the preparation of 1.
Related Compounds
Related Articles:
Selectivity of kinase inhibitor fragments.
2011-07-28
[J. Med. Chem. 54 , 5131-43, (2011)]
2006-11-15
[J. Am. Chem. Soc. 128 , 14426, (2006)]
2008-04-10
[J. Med. Chem. 51 , 2147-57, (2008)]
Rapid evolution of 6-phenylpurine inhibitors of protein kinase B through structure-based design.
2007-05-17
[J. Med. Chem. 50 , 2289-92, (2007)]